Details of the Drug

General Information of Drug (ID: DMKP9GO)

Drug Name

BNT152

Indication

Disease Entry	ICD 11	Status	REF
Aggressive cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

mRNA (modRNA)

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04710043) Phase I, First-in-human, Open-label, Dose Escalation Trial to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of BNT152+153 in Patients With Solid Tumors. U.S.National Institutes of Health.